The similar histopathological characteristics of alcoholic steatohepatitis (ASH) and non-alcoholic steatohepatitis (NASH), and the crucial role of the innate immune response in both conditions may lead to the assumption that ASH and NASH represent the same pathophysiological entities caused by different risk factors. In this review paper, we elaborate on the pathophysiological differences between these two entities and highlight the disease-specific involvement of signaling molecules downstream of the Toll-like receptor 4, and the differential mechanism by which the inflammasome contributes to ASH versus NASH. Our findings emphasize that ASH and NASH have disease-specific mechanisms and therefore represent distinct biological entities. Furt...
Non-alcoholic fatty liver disease (NAFLD) and alcohol-associated liver disease (ALD) represent a spe...
Abstract: Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflam...
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public hea...
So far, innate immune mechanisms have been recognized as the main responsible for the evolution of b...
Upregulation of the inflammatory cascade is a major element both in the progression of steatohepatit...
Hepatic steatosis and steatohepatitis are common histologic findings that can be caused by multiple ...
Hepatic steatosis and steatohepatitis are common histologic findings that can be caused by multiple ...
Alcoholic liver disease and nonalcoholic liver disease represent a leading cause of liver disease an...
Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation and...
International audienceNon-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifest...
Non-alcoholic steatohepatitis (NASH) is a disorder marked by alterations in hepatic lipid homeostasi...
Activation of inflammatory signaling pathways is of central importance in the pathogenesis of alcoho...
Inflammation and hepatocyte injury and death are the hallmarks of nonalcoholic steatohepatitis (NASH...
Excessive alcohol consumption is a leading cause of chronic liver disease in the Western world. Alco...
Abstract Immune and inflammatory pathways have a central role in the pathogenesis of non-alcoholic f...
Non-alcoholic fatty liver disease (NAFLD) and alcohol-associated liver disease (ALD) represent a spe...
Abstract: Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflam...
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public hea...
So far, innate immune mechanisms have been recognized as the main responsible for the evolution of b...
Upregulation of the inflammatory cascade is a major element both in the progression of steatohepatit...
Hepatic steatosis and steatohepatitis are common histologic findings that can be caused by multiple ...
Hepatic steatosis and steatohepatitis are common histologic findings that can be caused by multiple ...
Alcoholic liver disease and nonalcoholic liver disease represent a leading cause of liver disease an...
Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflammation and...
International audienceNon-alcoholic fatty liver disease (NAFLD) includes a range of hepatic manifest...
Non-alcoholic steatohepatitis (NASH) is a disorder marked by alterations in hepatic lipid homeostasi...
Activation of inflammatory signaling pathways is of central importance in the pathogenesis of alcoho...
Inflammation and hepatocyte injury and death are the hallmarks of nonalcoholic steatohepatitis (NASH...
Excessive alcohol consumption is a leading cause of chronic liver disease in the Western world. Alco...
Abstract Immune and inflammatory pathways have a central role in the pathogenesis of non-alcoholic f...
Non-alcoholic fatty liver disease (NAFLD) and alcohol-associated liver disease (ALD) represent a spe...
Abstract: Non-alcoholic steatohepatitis (NASH) is characterized by the presence of steatosis, inflam...
Non-alcoholic steatohepatitis (NASH), also known as fatty liver disease (FLD), is a major public hea...